| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8661950 | International Journal of Cardiology | 2018 | 34 Pages |
Abstract
Patients with CHF due to LVSD who receive beta-blocker were less likely to develop cachexia and more likely to have significant weight gain and better outcome compared to patients who did not receive or tolerate beta-blocker.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Shirley Sze, Pierpaolo Pellicori, Syed Kamzi, Alexandru Anton, Andrew L. Clark,